Arecor wins £2.8m from Innovate UK to boost fight against diabetes
Cambridge biopharma business Arecor has been awarded a £2.8 million grant from Innovate UK to support the Phase II development of AT247, an ultra-rapid acting insulin product candidate based on Arecor’s proprietary Arestat technology platform.
Psyomics pilots digital mental health assessment Censeo
UK healthtech firm Psyomics has begun pilots of its mental health assessment platform Censeo in two London GP practices, gathering real-world data and feedback before commercial launch later this year.
PhoreMost’s £33m investment success for disease targets
PhoreMost has completed a £33m Series B investment round.
Featurespace founder talks the future of financial crime & deep learning
We’ve seen the entrepreneurial spirit take off across the Southeast as founders have created new technologies in the wake of the pandemic.
Merchant Gourmet launches recycle scheme in tandem with Enval
Merchant Gourmet – the leading healthy pulses and grains brand – has launched An Appetite for Change Recycle Scheme by teaming up with innovative recycling partner Enval.
Paragraf launches advanced graphene-based Hall Effect sensor for mapping of battery cells
Paragraf, the leader in graphene-based transformative electronic devices, announces a new graphene Hall Effect sensor ideally suited to battery applications, such as the electric vehicle (EV) sector.
Covid-19: Cambridge scientists study DNA for long Covid clues
Scientists are investigating whether genetics impact on recovery from coronavirus, as part of research into "long Covid".
Axol Bioscience and Censo Biotechnologies announce merger
Axol Bioscience Ltd, an established provider of iPSC-derived cells, media, and characterisation services, and CENSO Biotechnologies, a cell biology CRO with focused expertise in iPSC-related technologies, today announced that the two companies have signed a merger agreement.
Could a new treatment for diabetic eye disease be on the horizon?
Academics from the University of Bristol have contributed to the development of a potential treatment for Diabetic Macular Oedema (DMO); an eye condition affecting more than 20 million diabetes patients. This potentially game-changing drug has now reached the clinical trial stage and will be tested on 48 patient volunteers.
Sorex Sensors founder honoured in Nova 111 global talent list
Dr Mario de Miguel Ramos, founder and CEO of University of Cambridge spin-out Sorex Sensors, has been named in the Nova 111 global talent list – which aims to recognise the “brightest stars” under 35. He features in the tech category of the list for his home country of Spain.
Cambridge/Bristol-based next gen positioning firm FocalPoint raises £6 million in Series B round
UK based deep-tech company FocalPoint has closed a Series-B round which saw a fresh £6 million line the coffers.
Antiverse raises £1.4 million to advance its AI antibody drug discovery platform
Antiverse, a biotechnology company developing a computational antibody drug discovery platform, has raised seed funding totalling £1.4 million ($2 million USD), comprising new investment and match funding from the UKI2S Innovate Accelerator. The funding will be used to further develop Antiverse’s AI antibody drug discovery platform, which rapidly and accurately predicts antibody-antigen binding to identify antibody drug candidates.
Silicon Valley stamp of approval for digital postage pioneer
Stamp Free Limited, a digital postage stamp company based in Cambridge and Edinburgh, has raised £300,000 to ramp up commercial traction and further develop its technology.
Stamp Free Launches World’s First Independent Digital Postage Stamp Targeting Post and Logistics Sectors
Funding secured from Silicon Valley’s Dr. Ronjon Nag and Cambridge Angels syndicate
VacuumLabs and Thought Machine forge global partnership
Vacuumlabs, the global provider of full-stack fintech solutions, today announced a global partnership with Thought Machine, the cloud native core banking technology company, following the two firms’ successful cooperation in Asia.
Healx and PKD Charity use AI to find cures for rare kidney diseases
Cambridge’s Healx, which uses AI to detect potential cures for rare diseases, has formed an alliance with the PKD Charity to probe novel treatments for kidney conditions. The specific target is to progress new cures for Autosomal Dominant Polycystic Kidney Disease (ADPKD) and Autosomal Recessive Polycystic Kidney Disease (ARPKD).
Former Honeywell director to drive Flusso global sales
Thomas Negre, previously global marketing director at Honeywell Analytics, has joined as VP sales and marketing at sensing solutions business Flusso in Cambridge to develop and lead the company’s go-to-market strategy.
Vivan Therapeutics joins global Repositive Cancer Model network
Repositive has announced that UK-based personalised therapeutics company Vivan Therapeutics will join its network of cancer model partners.
AML RightSource Acquires Arachnys Information Services
AML RightSource (“AMLRS” or the “Company”), the leading outsourced provider of Anti-Money Laundering (“AML”), Know Your Customer (“KYC”), and Bank Secrecy Act (“BSA”) compliance solutions, is pleased to announce it has acquired Arachnys Information Services Limited (“Arachnys”).
Nova Pangaea Technologies achieves technological validation of SARP (steam assisted rapid pyrolysis) technology
Nova Pangaea Technologies, based in Redcar, has reached a significant milestone in the development of its first-of-a-kind process to sustainably convert forestry and agricultural residues into sustainable biochemicals and biopolymers and drop-in products for advanced biofuels.